Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 172

Results For "company"

4439 News Found

Ami Organics inks MoU with a global manufacturer of electrolytes
News | December 22, 2023

Ami Organics inks MoU with a global manufacturer of electrolytes

Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business


Lupin launches liquid fibre Softovac Liquifibre
News | December 22, 2023

Lupin launches liquid fibre Softovac Liquifibre

Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients


JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
News | December 22, 2023

JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr

JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market


Abbott India MD Vivek Kamath resigns
People | December 22, 2023

Abbott India MD Vivek Kamath resigns

His resignation would be effective from March 18, 2024


Piramal Pharma Solutions commissions ADC manufacturing expansion in Scotland
News | December 21, 2023

Piramal Pharma Solutions commissions ADC manufacturing expansion in Scotland

The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant


FDA grants priority review to Merck’s new biologics license application for V116
Drug Approval | December 20, 2023

FDA grants priority review to Merck’s new biologics license application for V116

V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults


Clariant Healthcare debuts in CPhI India
News | December 20, 2023

Clariant Healthcare debuts in CPhI India

Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India


Venus Remedies' R3SET forays into wellness
News | December 20, 2023

Venus Remedies' R3SET forays into wellness

The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey


Briefs: Aurobindo Pharma and Granules Pharmaceuticals
Drug Approval | December 20, 2023

Briefs: Aurobindo Pharma and Granules Pharmaceuticals

Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection


AstraZeneca Pharma India to launch Enhertu in January 2024
News | December 20, 2023

AstraZeneca Pharma India to launch Enhertu in January 2024

Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer